Neuroketotherapeutics: A modern review of a century-old therapy

Neurochem Int. 2018 Jul;117:114-125. doi: 10.1016/j.neuint.2017.05.019. Epub 2017 Jun 1.

Abstract

Neuroketotherapeutics represent a class of bioenergetic medicine therapies that feature the induction of ketosis. These therapies include medium-chain triglyceride supplements, ketone esters, fasting, strenuous exercise, the modified Atkins diet, and the classic ketogenic diet. Extended experience reveals persons with epilepsy, especially pediatric epilepsy, benefit from ketogenic diets although the mechanisms that underlie its effects remain unclear. Data indicate ketotherapeutics enhance mitochondrial respiration, promote neuronal long-term potentiation, increase BDNF expression, increase GPR signaling, attenuate oxidative stress, reduce inflammation, and alter protein post-translational modifications via lysine acetylation and β-hydroxybutyrylation. These properties have further downstream implications involving Akt, PLCγ, CREB, Sirtuin, and mTORC pathways. Further studies of neuroketotherapeutics will enhance our understanding of ketone body molecular biology, and reveal novel central nervous system therapeutic applications.

Keywords: Alzheimer's disease; Bioenergetics; Ketogenic diet; Ketone bodies; Mitochondria; β-hydroxybutyrate.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / diet therapy
  • Alzheimer Disease / metabolism
  • Animals
  • Diet, Ketogenic / methods*
  • Diet, Ketogenic / trends
  • Energy Metabolism / physiology*
  • Epilepsy / diet therapy
  • Epilepsy / metabolism
  • Humans
  • Ketone Bodies / metabolism*
  • Ketosis / metabolism*
  • Mitochondria / metabolism*
  • Oxidative Stress / physiology

Substances

  • Ketone Bodies